Please login to the form below

Not currently logged in
Email:
Password:

Orion Pharma

This page shows the latest Orion Pharma news and features for those working in and with pharma, biotech and healthcare.

Bayer preps filings for new prostate cancer drug

Bayer preps filings for new prostate cancer drug

Bayer, which co-develops darolutamide with Finland’s Orion Pharma under the terms of a 2014 licensing deal, says it will discuss the data from ARAMIS with regulatory authorities to see ... Under the terms of their 2014 agreement, Bayer has the right to

Latest news

  • Alzheimer's disease pipeline takes multiple hits Alzheimer's disease pipeline takes multiple hits

    Other AChE inhibitors in phase II development include methanesulfonyl fluoride (SeneXta Therapeutics), ladostigil (Avraham), rilapladib (GlaxoSmithKline) and R-phenserine (QR Pharma). ... 2013). Orion Pharma is developing an oral 2c adrenergic receptor

  • 2011 IPA Best of Health Awards winners

    Puffalot', Easyhaler for Orion Pharma, by Langland. 'Rabbit', Easyhaler for Orion Pharma, by Langland. ... Healthcare Professional, Mixed Media Campaign. 'A Little Less Different', Easyhaler for Orion Pharma, by Langland.

  • PM Society Advertising Awards 2010

    Nursing Journal Advertisement. Easyhaler (puffalot) by Langland on behalf of Orion Pharma . Journal Advertisement Campaign. ... Patient Information Campaign. Modigraf Support Pack by Big Pink on behalf of Astellas Pharma Europe.

  • New Accounts, May, 2009, PR & Med Ed

    marketed by Orion Pharma UK.

  • New accounts: May

    Diabetes. Woolley Pau. Orion Pharma. Tridestra. HRT. Langland. Orion Pharma. Indivina.

More from news
Approximately 0 fully matching, plus 12 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics